

Overview
Chronic Kidney Disease (CKD) is defined as abnormalities of kidney structure or function present for more than three months, with implications for health. It is a major global public health issue, often progressing silently until advanced stages. In primary care, early identification is crucial to prevent complications, delay progression, and reduce cardiovascular risk. Given the high prevalence and often asymptomatic nature of early CKD, especially in populations with diabetes, hypertension, and cardiovascular disease, primary care providers play a critical role in screening and diagnosis.
Challenges in primary care include under-recognition of early CKD, lack of awareness about guideline-based classification, and missed opportunities for early referral or intervention. Early identification and diagnosis of CKD in primary care is vital for improving long-term outcomes. CKD screening in at-risk individuals, awareness of diagnostic thresholds, and CKD classification or CKD staging using KDIGO criteria are essential steps.
CKD screening should be targeted toward high-risk groups rather than the general population. The recommended screening tests are simple and cost-effective: estimation of the glomerular filtration rate (eGFR) using serum creatinine, and detection of albuminuria through a urine albumin-to-creatinine ratio (ACR). Diagnosis of CKD requires the persistence of kidney abnormalities for at least three months. CKD classification or CKD staging of the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines is based on cause, GFR category (G1–G5), and albuminuria category (A1–A3), which helps guide risk stratification and management decisions. Laboratory results should always be interpreted within the clinical context, considering transient causes of reduced kidney function or proteinuria. Integrating decision support tools, such as the Kidney Failure Risk Equation (KFRE), can help identify patients who may need nephrology referral.
This learning activity will equip primary care physicians with knowledge and tools to screen and diagnose CKD early and perform timely specialist referrals, ultimately contributing to reducing the burden of kidney failure and its complications.
At the end of this learning module, participants should be able to:
Dr Lee-Boyd D. Valencia, MD, FPCP, FPSN
Internal Medicine and Nephrology Consultant
St. Luke’s Medical Center Global City
St. Luke’s Medical Center Quezon City
Fellow, Philippine Society of Nephrology
Fellow, Philippine College of Physicians
Member, International Society of Nephrology
Member-Secretary, St. Luke’s Medical Center Institutional Ethics Review Committee
Hemodialysis Clinical Unit Head, San Fernando Hemodialysis Center Corporation
Head of Hemodialysis Section, United Doctors Medical Center Quezon City
Member, Philippine Society of Nephrology Research Committee